Analyst Ratings January 30, 2026

Truist Lifts Robert Half Price Target to $40, Keeps Buy Rating Despite EPS Cuts

Analyst raises target amid long-term confidence even as near-term earnings projections are trimmed and Q4 2025 delivered a small beat

By Jordan Park RHI
Truist Lifts Robert Half Price Target to $40, Keeps Buy Rating Despite EPS Cuts
RHI

Truist Securities increased its price target on Robert Half (RHI) to $40 from $35 and maintained a Buy rating, while trimming EPS estimates for 2026 and 2027 due to higher expected SG&A costs. The staffing firm reported a modest fourth-quarter 2025 earnings and revenue beat, and its shares have fallen more than 55% over the past year, currently trading near fair value per InvestingPro data.

Key Points

  • Truist increased its price target on Robert Half to $40 from $35 and maintained a Buy rating.
  • The brokerage lowered EPS estimates for 2026 and 2027 because it expects higher SG&A costs in those years.
  • Robert Half beat fourth-quarter 2025 estimates with $0.32 EPS and $1.3 billion in revenue; no recent M&A was reported.

Analyst action and rating

Truist Securities raised its price target on Robert Half (NYSE: RHI) to $40.00 from $35.00 and held its Buy rating on the staffing company's shares. The move accompanies lowered near-term earnings projections even as the brokerage expressed continued confidence in the company's longer-term prospects.

Earnings estimate revisions

The firm reduced its earnings per share estimate for fiscal 2026 to $1.40, down from a prior projection of $1.71. Truist characterized this as an 18 percent reduction in expected EPS for that year. The brokerage also cut its 2027 EPS estimate to $2.50 from $2.88. Those downward revisions are attributed to assumptions of higher selling, general and administrative expenses in both 2026 and 2027.

Context from recent results

Robert Half reported fourth-quarter 2025 results that exceeded analysts' consensus. The company posted earnings per share of $0.32 versus a forecast of $0.30, a 6.67 percent surprise. Revenue for the quarter totaled $1.3 billion, narrowly topping an expected $1.29 billion. The announcement was followed by analyst evaluations, though no specific upgrades or downgrades were cited in connection with the quarter's release. The company did not report any recent mergers or acquisitions.

Stock performance and valuation

The shares have experienced significant decline, falling by more than 55 percent over the prior year. InvestingPro data referenced by the reporting indicates Robert Half is trading near its Fair Value at present.

Implications and takeaway

Truist's decision to raise the price target while lowering near-term EPS estimates reflects a separation between an expectation of higher short-term costs and a more positive view of Robert Half's medium to long-term business fundamentals. The combination of a maintained Buy rating and an elevated target suggests the analyst sees upside potential despite recent weakness in the share price and tighter near-term profitability assumptions.


Summary box

  • Truist raised its price target on Robert Half to $40 from $35 and kept a Buy rating.
  • Truist trimmed 2026 EPS to $1.40 from $1.71 and 2027 EPS to $2.50 from $2.88 due to higher projected SG&A.
  • Robert Half beat Q4 2025 expectations with EPS of $0.32 and revenue of $1.3 billion.

Risks

  • Higher-than-expected SG&A costs in 2026 and 2027 could continue to pressure near-term earnings, affecting the staffing sector and corporate service providers.
  • Significant share price decline of over 55 percent in the past year indicates elevated equity volatility and suggests market sensitivity to earnings revisions.
  • Trading near Fair Value per InvestingPro data may limit immediate upside absent clearer improvement in cost structure or margin outlook, impacting investors in labor-services and staffing stocks.

More from Analyst Ratings

Ascendiant Capital Starts Coverage on Synergy CHC With Buy Rating and $5 Target Feb 2, 2026 Citi Raises Teck Resources to Buy, C$104 Target Tied to Anglo American Deal Feb 2, 2026 Goldman Sachs Moves Futu to Buy Citing Strong Client Growth Forecasts Feb 2, 2026 Morgan Stanley Starts Coverage of Circle With Neutral Rating, Flags Rate Headwinds and Revenue Concentration Feb 2, 2026 Morgan Stanley Lowers Humana Rating, Flags Medicare Advantage Risks Feb 2, 2026